House Roll Call 133, 117th Congress · May 11, 2021

Fairness in Orphan Drug Exclusivity Act

Question before the chamber: On Motion to Suspend the Rules and Pass

250 yea · 168 nayFailed12 not voting or present

Democrat214 yea · 0 nay

Republican36 yea · 168 nay

Solid = yea, faded = nay.

The measure

H.R. 1629 ↗

Fairness in Orphan Drug Exclusivity Act

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

Health CareDirection unreadable — not scored
excluded:model-unclear (0.70) Narrowing orphan drug exclusivity regulates pharmaceutical competition rather than directly expanding health insurance coverage.
Tagged by: policy-area:Health
Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (250)

Nay (168)

Not voting or present (12)

Michael C. BurgessDid not vote
G. K. ButterfieldDid not vote
Rodney DavisDid not vote
Peter A. DeFazioDid not vote
Neal P. DunnDid not vote
Jared F. GoldenDid not vote
Barry MooreDid not vote
Richard E. NealDid not vote
Burgess OwensDid not vote
Pete SessionsDid not vote
Glenn ThompsonDid not vote
Daniel WebsterDid not vote

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.